يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Tasa de recaída"', وقت الاستعلام: 0.58s تنقيح النتائج
  1. 1
    Dissertation/ Thesis

    المؤلفون: Niño Quiroga, Laura Isabel

    المساهمون: Linares Ballesteros, Adriana, Yunis Londoño, Juan José, García Medina Johnny Francisco, Yunis Hazbún Luz Karime, Aponte Barrios Nelson Hernando

    وصف الملف: 1 recurso en línea (73 páginas); application/pdf

    Relation: PUI, Ching-Hon (ed.). Childhood leukemias. Cambridge university press, 2012.; Xie S, Hossain J. Survival di ff erences in childhood and young adult acute myeloid leukemia : A cross-national study using US and England data. Cancer Epidemiol. 2018;54(March):19-24. doi:10.1016/j.canep.2018.03.001; Susan E. Puumala, PhD, Julie A. Ross, PhD, Richard Aplenc, MD, PhD, and Logan G. Spector P. Epidemiology of Childhood Acute Myeloid Leukemia. Pediatr Blood Cancer. 2013;(60):728–733. doi:DOI 10.1002/pbc.24464; De Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the united states: Prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561-570. doi:10.1158/1055-9965.EPI-12-1356; Lins MM, Julia M, Mello G, Ribeiro RC, Camargo B De, Fátima M De. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low – middle-income country. 2019.; Vardiman JW, Arber DA, Orazi A, et al. The 2016 revision to the World Health Organization classi fi cation of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2406. doi:10.1182/blood-2016-03-643544.The; Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med. 2016;374(23):2209-2221. doi:10.1056/NEJMoa1516192; Gamis AS, Alonzo TA, Meshinchi S, et al. Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children’s Oncology Group Trial AAML0531. J Clin Oncol. 2014;32(27):3021-3032. doi:10.1200/JCO.2014.55.3628; Creutzig U, Heuvel-eibrink MM Van Den, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents : recommendations from an international expert panel Diagnosis and management of acute myeloid leukemia in children and adolescents : recommendations from an international expert panel. 2012:3187-3205. doi:10.1182/blood-2012-03-362608; Upadhyay VA, Fathi AT. Induction chemotherapy in acute myeloid leukaemia: Origins and emerging directions. Curr Opin Hematol. 2018;25(2):67-74. doi:10.1097/MOH.0000000000000407; Costo C de alto. Situación Del Cáncer En La Población Pediatrica Atendida En El SGSSS de Colombia.; 2017. https://cuentadealtocosto.org/site/images/Libro_Situacion_Cancer_Pediatrico_2017.pdf.; Taga T, Tomizawa D, Takahashi H, Adachi S. Acute myeloid leukemia in children: Current status and future directions. Pediatr Int. 2016;58(2):71-80. doi:10.1111/ped.12865; Revista Colombiana de Cancerología. 2020;24(2):72-79.; Isabel M, Rumilla V, Ballesteros AL, et al. Pediatric Research and Child Health Signs , Symptoms and Findings in Complete Blood Cell Count at Diagnosis in Children with Acute Leukemia. 2018;1(1).; Johnston DL, Woods WG, Alonzo TA, et al. Central nervous system disease in pediatric acute myeloid leukemia : A report from the Children ’ s Oncology Group. 2017;(January):1-9. doi:10.1002/pbc.26612; Jaime-pérez JC, Padilla-medina JR, Fernández LT, et al. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center. Clin Lymphoma, Myeloma Leuk. 2018:1-7. doi:10.1016/j.clml.2018.02.002; Ofran Y, Rowe JM. Introducing minimal residual disease in acute myeloid leukemia. Curr Opin Hematol. 2015;22(2):139-145. doi:10.1097/MOH.0000000000000113; Ossenkoppele G, Schuurhuis GJ. MRD in AML : does it already guide therapy decision-making ? :356-365.; Loken MR, Alonzo TA, Pardo L, et al. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia : a report from Children ’ s Oncology Group. 2012;120(8):1581-1588. doi:10.1182/blood-2012-02-408336.; Rubnitz JE, Inaba H, Dahl G, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial. Lancet Oncol. 2010;11(6):543-552. doi:10.1016/S1470-2045(10)70090-5; Article O. Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse. 2014;(January):1-10. doi:10.1038/leu.2014.186; Creutzig U, Van Den Heuvel-Eibrink MM, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: Recommendations from an international expert panel. Blood. 2012;120(16):3167-3205. doi:10.1182/blood-2012-03-362608; Horan JT, Alonzo TA, Lyman GH, et al. Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: The Children’s Oncology Group. J Clin Oncol. 2008;26(35):5797-5801. doi:10.1200/JCO.2007.13.5244; Klein K, Dors N, Tissing WJE, et al. Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia : Recent experiences of the Dutch Childhood Oncology Group. 2019;(November):1-10. doi:10.1002/pbc.28099; Bochennek K, Hassler A, Perner C, et al. Infectious complications in children with acute myeloid leukemia : decreased mortality in multicenter trial. 2016;(November 2015):8-11. doi:10.1038/bcj.2015.110; Creutzig U, Zimmermann M. Longitudinal Evaluation of Early and Late Anthracycline Cardiotoxicity in Children With AML. 2007;(July 2006):651-662. doi:10.1002/pbc; https://repositorio.unal.edu.co/handle/unal/79411; Universidad Nacional de Colombia; Repositorio Institucional Universidad Nacional de Colombia; https://repositorio.unal.edu.co/

  2. 2